TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 29 filers reported holding TRINITY BIOTECH PLC in Q2 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $45,000 | -22.4% | 42,365 | +3.9% | 0.00% | – |
Q4 2021 | $58,000 | -58.3% | 40,756 | -36.7% | 0.00% | – |
Q3 2021 | $139,000 | -37.4% | 64,424 | +9.2% | 0.00% | – |
Q1 2021 | $222,000 | -40.3% | 59,019 | -39.5% | 0.00% | – |
Q4 2020 | $372,000 | +962.9% | 97,512 | +464.3% | 0.00% | – |
Q3 2020 | $35,000 | -70.8% | 17,280 | -84.1% | 0.00% | – |
Q1 2020 | $120,000 | -26.4% | 108,984 | -31.1% | 0.00% | – |
Q4 2019 | $163,000 | -12.8% | 158,108 | +2.0% | 0.00% | – |
Q3 2019 | $187,000 | -36.8% | 155,019 | -3.2% | 0.00% | – |
Q2 2019 | $296,000 | -32.9% | 160,089 | +3.4% | 0.00% | -100.0% |
Q1 2019 | $441,000 | +23.2% | 154,889 | -0.8% | 0.00% | 0.0% |
Q4 2018 | $358,000 | -45.6% | 156,146 | -5.1% | 0.00% | 0.0% |
Q3 2018 | $658,000 | -22.5% | 164,502 | -3.1% | 0.00% | 0.0% |
Q2 2018 | $849,000 | -53.5% | 169,712 | -52.1% | 0.00% | -50.0% |
Q1 2018 | $1,824,000 | -11.4% | 354,142 | -12.3% | 0.00% | -33.3% |
Q4 2017 | $2,058,000 | +9.8% | 403,587 | +20.8% | 0.00% | 0.0% |
Q3 2017 | $1,874,000 | -16.8% | 334,118 | -11.0% | 0.00% | -25.0% |
Q2 2017 | $2,252,000 | -0.1% | 375,379 | -0.8% | 0.00% | 0.0% |
Q1 2017 | $2,255,000 | -43.2% | 378,356 | -34.0% | 0.00% | -50.0% |
Q4 2016 | $3,967,000 | -5.1% | 573,300 | +81.2% | 0.01% | +14.3% |
Q3 2016 | $4,182,000 | +54.3% | 316,320 | +32.3% | 0.01% | +16.7% |
Q2 2016 | $2,711,000 | +31.3% | 239,080 | +35.1% | 0.01% | +20.0% |
Q1 2016 | $2,064,000 | -66.4% | 177,003 | -66.2% | 0.01% | -61.5% |
Q4 2015 | $6,152,000 | +131.2% | 523,102 | +124.9% | 0.01% | +160.0% |
Q3 2015 | $2,661,000 | +193.4% | 232,596 | +363.1% | 0.01% | +150.0% |
Q2 2015 | $907,000 | -87.2% | 50,229 | -86.4% | 0.00% | -84.6% |
Q1 2015 | $7,089,000 | +29.2% | 368,248 | +17.5% | 0.01% | +8.3% |
Q4 2014 | $5,487,000 | +2148.8% | 313,365 | +2853.8% | 0.01% | +1100.0% |
Q2 2014 | $244,000 | – | 10,609 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |